In the BioHarmony Drug Report Database

"Preview" Icon

Nepafenac

Ilevro, Nevanac (nepafenac) is a small molecule pharmaceutical. Nepafenac was first approved as Ilevro on 2005-08-19. It is used to treat eye pain in the USA. It has been approved in Europe to treat ophthalmologic surgical procedures and postoperative pain. Nevanac’s patents are valid until 2032-03-31 (FDA).

 

Trade Name

 

Nevanac
 

Common Name

 

nepafenac
 

ChEMBL ID

 

CHEMBL1021
 

Indication

 

eye pain, ophthalmologic surgical procedures, postoperative pain
 

Drug Class

 

Anti-inflammatory agents (acetic acid derivatives)

Image (chem structure or protein)

Nepafenac structure rendering